Related Experiment Video
Updated: Aug 10, 2026

Cell-based Calcium Assay for Medium to High Throughput Screening of TRP Channel Functions using FlexStation 3
Published on: August 17, 2011
The calcium antagonists in the 1990s. An overview
1Department of Medicine, University of Alabama, Birmingham 35294.
Calcium antagonists effectively treat hypertension and may prevent vascular complications. These agents show promise in slowing early atherosclerotic lesion progression and protecting kidneys, with potential neuroprotective benefits.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Nephrology
Background:
- Essential hypertension management is crucial for preventing vascular complications.
- Calcium antagonists offer a unique therapeutic profile beyond blood pressure reduction.
- Understanding their multifaceted effects is key to optimizing cardiovascular and renal outcomes.
Purpose of the Study:
- To evaluate the efficacy of calcium antagonists in treating essential hypertension.
- To assess their role in preventing vascular complications, including atherosclerosis and stroke.
- To investigate their renoprotective effects in hypertensive patients.
Main Methods:
- Review of clinical trial data on calcium antagonists in hypertension.
- Analysis of studies investigating antiatherosclerotic effects in coronary arteries and grafts.
- Examination of evidence for neuroprotective and renoprotective mechanisms.
Main Results:
- Calcium antagonists are effective antihypertensives and may inhibit early atherosclerotic lesion formation.
- Preliminary data suggest they retard early lesion progression but have less impact on established lesions.
- Evidence indicates renoprotective effects independent of blood pressure lowering and efficacy in reducing stroke-related brain damage.
Conclusions:
- Calcium antagonists possess a broad therapeutic role in managing hypertension and its complications.
- Their antiatherosclerotic, cardioprotective, neuroprotective, and renoprotective properties warrant further investigation.
- Further long-term studies are needed to confirm sustained clinical benefits in diverse patient populations.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...

